Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report

January 1 – September 30, 2017The third quarter in figures · Net sales amounted to TSEK 1,172 (1,580). · The loss after tax amounted to TSEK 8,810 (12,395). · The loss per share amounted to SEK 1.06 (1.50). · The cash flow from current operations was negative in the amount of TSEK 9,796 (10,459). · The gross margin in the period was 56.8 (44.6)%. · Electrode sales in volume grew in total by 9% and reached 3,440 (3,168) units. Repeat sales of electrodes grew by 42%. The first 9 months in figures · Net sales amounted to TSEK 4,973 (4,501). · The loss after tax

Nynas reports third quarter 2017

Sales volumes increased with 10 per cent in the third quarter. The operating result (EBITDA) amounted to SEK 311 million (541), negatively impacted by a weaker USD and sourcing limitations primarily in the Americas.“The third quarter was disappointing for Nynas with financial performance below expectations and previous year even though sales continued to develop positively,” commented Gert Wendroth, President and CEO of Nynas AB. THIRD QUARTER SUMMARY · Total product sales volumes increased by 10 per cent compared to the third quarter 2016. · Net sales increased to SEK 4,538

INVITATION TO Q3 2017 PRESENTATION

Techstep ASA will release its third quarter results on Friday 17 November at 7.00 am CET. The quarterly report and presentation will be made available on the company’s website www.techstepasa.no and www.newsweb.no. CEO Gaute Engbakk and CFO Marius Drefvelin will present the company’s results at 9:00 am CET at SpareBank 1 Markets, Olav V’s gate 5, in Oslo. The presentation will be given in Norwegian, with supporting material in English. The Q3 presentation can also be followed through live audio webcast. Webcast – audio and slide presentationPlease join the Q3 2017 results webcast

Herantis Pharma's Manager's Transactions

Herantis Pharma's Manager's Transactions Herantis Pharma PlcCompany release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Mattila, Pekka Position: Member of the Board/Deputy member Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20171109210453_4 ____________________________________________ Transaction date: 2017-11-09 Venue: FIRST NORTH FINLAND (

Herantis Pharma's Manager's Transactions

Herantis Pharma's Manager's Transactions Herantis Pharma PlcCompany release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Wuite, Frans Position: Member of the Board/Deputy member Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20171109211444_2 ____________________________________________ Transaction date: 2017-11-09 Venue: FIRST NORTH FINLAND (FNFI)

Herantis Pharma's Manager's Transactions

Herantis Pharma's Manager's Transactions Herantis Pharma PlcCompany release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Simula, Pekka Position: Chief Executive Officer Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20171109211640_5 ____________________________________________ Transaction date: 2017-11-09 Venue: FIRST NORTH FINLAND (FNFI)

Herantis Pharma's Manager's Transactions

Herantis Pharma's Manager's Transactions Herantis Pharma PlcCompany release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Veromaa, Timo Position: Member of the Board/Deputy member Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20171109211633_2 ____________________________________________ Transaction date: 2017-11-09 Venue: FIRST NORTH FINLAND (FNFI)

Elekta MR-linac functionality and CE mark update (Correction)

STOCKHOLM, November 10, 2017 – Elekta (EKTA-B.ST) has decided to add additional functional imaging capabilities to its MR-linac (Unity) and to spend more time on validating its linac control system in order to offer clinicians the unparalleled opportunities of its high field strength from the first release. Consequently, CE mark for Unity is currently expected during the first half of 2018 instead of the end of 2017.During 2017, Elekta successfully unveiled Unity in both Europe and the U.S. A first-in-man-study at the University of Utrecht and studies at other university hospitals confirmed

ICA Gruppen’s sustainability report for third quarter 2017

ICA Gruppen’s greenhouse gas emissions decreased during the period. The continued decrease is mainly attributable to the changeover to renewable fuels in the Swedish operations and further investments in renewable electricity at Rimi Baltic.“During the quarter we continued our work on achieving our ambitious climate target, among other things by further reducing our emissions and increasing our resource efficiency. I am very happy to note that we soon will have halved our emissions compared with the base year 2006. This shows that we are well on our way to achieving this target,” commented

Skanska invests EUR 44M, about SEK 420M, in a new office building in Krakow, Poland

Skanska invests EUR 44M, about SEK 420M in the next building of High5ive, a five-building office complex located in Krakow, Poland. The investment considers the third building as well as underground parking levels for both the third and the fourth building. The building under construction will offer a total leasable area of about 12,000 square meters.High5ive, Skanska’s largest office development in Krakow, has a central location next to Krakow's main railway station. The complex will feature an area for leisure and co-working, a mini-stage for small events and concerts and the Bike5ive

Interim report July–September 2017

July–September 2017  · Net sales increased by 19% to SEK 3,926 million (3,289) · Organic growth was 6% (-4) · The order backlog was 25% higher at SEK 10,635 million (8,475) · Operating profit increased by 17% to SEK 222 million (189) · The operating margin was 5.7% (5.8) · Adjusted operating profit was SEK 222 million (200)  · The adjusted operating margin was 5.7% (6.1) · Profit after tax was SEK 164 million (133) · Cash flow from operating activities was SEK -144 million (-57) · Net debt amounted to SEK 2,515 million (2,783) · One acquisition was made in

Getinge's Board of Directors proposes a distribution of the Patient & Post-Acute Care business area to Getinge's shareholders

The Board of Directors of Getinge AB ("Getinge") has today proposed that the shareholders of Getinge shall decide, at an Extraordinary General Meeting in Getinge, to distribute the Patient & Post-Acute Care business area ("PPAC", previously Extended Care) through a distribution of all shares in the wholly-owned subsidiary Arjo AB (publ), corporate registration number 559092-8064 ("Arjo"), including the underlying Group, to the shareholders of Getinge. The proposal includes the distribution of all shares in Arjo, where each share of series A in Getinge entitles to one share of series A in

Revised strategy, new financial targets and restated financial information for Getinge (excluding Arjo)

Following the strategic review and the proposed distribution and listing of the business area Patient & Post-Acute Care (now called Arjo), the Board of Directors of Getinge has decided on a revised strategy, new financial targets and present restated historical financial information for Getinge excluding Arjo.New financial targetsAs a result of the proposed distribution and listing of Patient & Post-Acute Care and the related area disinfection flushers, now called Arjo, the Board of Directors of Getinge has decided on new financial targets based on the revised strategy for Getinge

Notice of Extraordinary General Meeting in Getinge AB

The shareholders of Getinge AB (publ) are hereby invited to attend the Extraordinary General Meeting (the “EGM”) to be held on Monday, December 4, 2017 at 16.00 CET, at Elite Park Avenue Hotel, Kungsportsavenyn 36-38 in Gothenburg, Sweden. Right to attend Shareholders who wish to attend the EGM must: –       be recorded in the share register kept by Euroclear Sweden AB (the Swedish Central Securities Depository), on Tuesday, November 28, 2017, and –       notify the company of their intention to attend the EGM by Tuesday, November 28, 2017, preferably before 4.00 p.m. CET. In

Magnolia Bostad is awarded four land allotments in Stockholm comprising a total of 355 apartments

Magnolia Bostad has, in competition with approximately 30 developers, been awarded one land allotment in Skärholmsdalen, one in Skarpnäcks gård and two allotments in Årstaberg.The land allotment in Skärholmen concerns part of the property Skärholmen 2:1 and comprises approximately 9,000 square meters of land where Magnolia Bostad will develop approximately 85 apartments. The area is part of the Fokus Skärholmen-project, which will provide attractive residential areas with proximity to nature, biketrails and footpaths, SKHLM and Kungens Kurva. The area also has good metro connections with 20

Pandox AB (publ) interim report January – September 2017

Good growth and high efficiencyQuarter July – September 2017 · Revenue from Property Management amounted to MSEK 589 (479). Adjusted for currency effects and comparable units, the increase was 4 percent. · Net operating income from Property Management amounted to MSEK 511 (409). Adjusted for currency effects and comparable units, the increase was 3 percent. · Net operating income from Operator Activities amounted to MSEK 129 (130). Adjusted for currency effects and comparable units, the increase was 44 percent. · EBITDA amounted to MSEK 610 (512). · Profit for the period

Webstep – Stabilisation notice and exercise of greenshoe option

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.Oslo, 10 November 2017: Reference is made to the announcement issued by Webstep ASA ("Webstep" or the "Company") and Arctic Securities AS (the "Stabilisation Manager") on 11 October 2017 regarding potential

Multiconsult ASA – Repurchase of own shares

On 9 November 2017, Multiconsult ASA ("Multiconsult") purchased 5 434 of its own shares at an average price of NOK 82.11 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 123 528 of its own shares.  For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

ICA Gruppen Q3 report 2017

Stable earnings performance – high growth in e-commerceThird quarter of 2017 in summary · Consolidated net sales amounted to SEK 26,428 million (25,752), an increase of 2.6% · Operating profit excluding non-recurring items totalled SEK 1,380 million (1,376) · The sale of ICA Eiendom in Norway and costs ahead of the integration of the acquisition of IKI in Lithuania affected operating profit excluding nonrecurring items by a combined total of SEK -41 million · Profit for the period was SEK 1,100 million (1,070). Profit includes capital gains on sales of non-current assets and

Navamedic ASA: Q3 2017 results

Oslo, November 10, 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 44.9 million in the third quarter of 2017, down from NOK 65.2 million in the same period in 2016, following the planned discontinuation of the Aspen agreement. Excluding Aspen, the revenues for the quarter was up 52% to NOK 43 million. Navamedic is also reviewing strategic alternatives, including partnering and co-investments, to accelerate and leverage the Sippi® growth opportunity. "The third quarter marks the first period following the discontinuation of the Aspen agreement, which is reflected in the

Large inflows into equity funds

In October, investment funds recorded a total net inflow of SEK 6,9 billion. The largest deposits were made in equity funds with a net inflow of SEK 10,2 billion. The total fund assets in Sweden increased during the month and amounted at the end of October to the new record high level of SEK 3 996 billion.Investment funds recorded a total net inflow of SEK 6,9 billion in October. Equity funds had net inflows of SEK 10,2 billion. Balanced funds and money market funds on the other hand recorded net outflows of 3,8 and 5,4 billion respectively. “Except large inflows in Sweden and global

Selvaag Bolig ASA: Transcript of third quarter presentation

Attached, a transcript in English of the third quarter presentation given in Norwegian 9 November at 09:00 CET. Further information fromKristoffer Gregersen, vice president communications and marketing, Selvaag Bolig ASATelephone: +47 957 75 593, e-mail: kgr@selvaagbolig.no Selvaag Bolig ASA is a residential property developer controlling the entire value chain from acquisition of land to sale of homes. The company has several thousand homes under development at any given time, and focuses on the growth areas in and around Greater Oslo, Bergen, Stavanger and Trondheim. Selvaag

Fall is Here and So are Deer

Insurers say make sure you have adequate auto coverage It’s that time of year when deer are more active and more likely to dash across a road or highway. While sometimes it’s impossible to avoid hitting a deer, according to the Property Casualty Insurers Association of America (PCI), motorists can take simple steps to prevent deer crashes and hopefully prevent injuries and thousands of dollars in vehicle damage. “While we all try our best to avoid deer-related crashes, the good news is that they are covered by automobile insurance if you have comprehensive coverage, and insurers will

Cantargia: Combined directed issue and fully guaranteed rights issue of 232 MSEK for its expanded clinical program of immuno-oncology antibody CAN04

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL The Board of Directors of Cantargia AB (publ) ("Cantargia" or the "Company") resolved on November 9, 2017 to carry out a directed new share issue of approximately SEK 101 million and a fully guaranteed rights issue of approximately SEK 131 million. The Board's resolution requires approval by an Extraordinary General Meeting on November 27, 2017. Notice of the

There are no items matching the current filter
There are no more items matching the current filter
Back to top